Conversion of TNF alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by

G C Kaiser1, F Yan, D B Polk

  • 1Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232, USA.

Insights

Tumor necrosis factor alpha (TNFα) and epidermal growth factor (EGF) activate mitogen-activated protein (MAP) kinases in intestinal cells. The timing and location of MAP kinase activity influence cell proliferation, impacting gut health.

Area of Science:

  • Cell biology
  • Gastroenterology
  • Molecular signaling

Background:

  • Intestinal epithelial cell proliferation and differentiation are crucial for mucosal barrier integrity.
  • Mitogen-activated protein (MAP) kinases are key signal transducers in these cellular processes.
  • Understanding MAP kinase regulation by specific ligands is vital for comprehending intestinal homeostasis.

Purpose of the Study:

  • To investigate how tumor necrosis factor alpha (TNFα) and epidermal growth factor (EGF) regulate MAP kinase activity in intestinal epithelial cells.
  • To determine the impact of MAP kinase kinetics and subcellular localization on cell proliferation.
  • To explore the implications for inflammatory bowel disease.

Main Methods:

  • Utilized the young adult mouse colon (YAMC) cell line.
  • Administered TNFα and/or EGF, with and without the MEK1 inhibitor PD 98059.
  • Assessed cell proliferation via hemocytometry.
  • Identified activated MAP kinase using Western blot, in vitro kinase assays, and confocal microscopy.

Main Results:

  • Both TNFα and EGF activated MAP kinase in intestinal epithelial cells.
  • TNFα induced sustained nuclear MAP kinase activity, while EGF induced transient cytoplasmic activity.
  • Modifying TNFα's sustained activation to transient altered its effect from anti-proliferative to proliferative.

Conclusions:

  • The kinetics and subcellular localization of MAP kinase activation by TNFα and EGF are critical for divergent cellular responses in the intestinal epithelium.
  • These findings highlight the role of MAP kinase signaling in regulating intestinal cell fate.
  • Understanding these pathways offers insights into altered proliferative signals in inflammatory bowel disease.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...